1
|
Cifuentes-González C, Le Tong Y, Mejía-Salgado G, Chan R, Walter CFY, Rojas-Carabali W, Putera I, Mobasserian A, Nora RLD, Biswas J, Gangaputra S, Pulido JS, Kempen JH, Nguyen QD, de la Torre A, Gupta V, Rosenbaum JT, Agrawal R. Global demographic and etiological variations of retinal vasculitis: A systematic review and meta-analysis: International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) Report 1. Surv Ophthalmol 2025:S0039-6257(25)00023-2. [PMID: 39921003 DOI: 10.1016/j.survophthal.2025.01.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2024] [Revised: 01/23/2025] [Accepted: 01/30/2025] [Indexed: 02/10/2025]
Abstract
This systematic review with meta-analysis explores the global demographic and etiological variations of retinal vasculitis (RV), focusing on differences in frequency, age, sex, and etiology across diverse geographic populations. RV is an inflammatory condition that can lead to visual impairment, making understanding its variations essential for targeted screening and management. Systematic searches were conducted in multiple databases up to February, 2023, following PRISMA guidelines. We included studies with at least 10 RV, such that a frequency measurement can be estimated, without restrictions on publication date or language. RV was categorized as Idiopathic RV in the absence of additional ocular or systemic disease, Syndromic RV for ocular involvement without systemic disease, and Secondary RV with systemic disease. The risk of bias was evaluated using standardized tools. A total of 95 studies, including 23,180 patients, were analyzed. The overall RV frequency among uveitis cohorts was 17%, with European populations showing the highest frequency at 25%. Idiopathic RV accounted for 1% of uveitis cohorts and 38% of RV cohorts, with significant differences across continents. Behçet disease had the highest RV frequency at 56%. The median age of diagnosis was 33.5 years, and RV was more frequent in males (57%). The overall RV frequency among uveitis cohorts was 17%, while Idiopathic RV represented 1% of uveitis cohorts and 38% of RV cohorts. Our findings underscore the considerable geographic and demographic variability in RV, particularly in Idiopathic RV, tuberculosis-related RV, and Behçet disease, highlighting the need for tailored, region-specific, and gender-specific approaches to RV diagnosis and treatment.
Collapse
Affiliation(s)
- Carlos Cifuentes-González
- National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Programme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore
| | - Yong Le Tong
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | - Germán Mejía-Salgado
- Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT). Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia
| | - Reo Chan
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore
| | | | - William Rojas-Carabali
- National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Programme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
| | - Ikhwanuliman Putera
- Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Azadeh Mobasserian
- Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, USA
| | - Rina La Distia Nora
- Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia - Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia
| | - Jyotirmay Biswas
- Department of Uvea and Ocular Pathology, Sankara Nethralaya, Chennai, Tamil Nadu, India
| | - Sapna Gangaputra
- Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, USA
| | - Jose S Pulido
- Ocular Oncology Service, Wills Eye Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA, USA; Bower Laboratory for Translational Medicine, Vickie and Jack Farber Vision Research Center at Wills Eye Hospital, Wills Eye Hospital, Philadelphia, PA, USA
| | - John H Kempen
- Department of Ophthalmology and Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary; and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA; Sight for Souls, Bellevue, Washington, USA; MCM Eye Unit; MyungSung Christian Medical Center (MCM) Comprehensive Specialized Hospital and MyungSung Medical College, Addis Ababa, Ethiopia; Department of Ophthalmology, Addis Ababa University School of Medicine, Addis Ababa, Ethiopia
| | - Quan Dong Nguyen
- Spencer Center for Vision Research, Byers Eye Institute, Stanford University, Palo Alto, CA, USA
| | - Alejandra de la Torre
- Neuroscience (NEUROS) Research Group, Neurovitae Research Center, Institute of Translational Medicine (IMT). Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá, Colombia
| | - Vishali Gupta
- Advanced Eye Centre, Post, graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
| | | | - Rupesh Agrawal
- National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Programme for Ocular Inflammation & Infection Translational Research, Department of Ophthalmology, National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore; Singapore Eye Research Institute, Singapore; Duke NUS Medical School, Singapore
| |
Collapse
|
3
|
Elgengehy FT, Gamal SM, Sobhy N, Siam I, Soliman AM, Elhady GW, Gheita TA. Vasculitis damage index in Behçet's disease. Adv Rheumatol 2021; 61:33. [PMID: 34108037 DOI: 10.1186/s42358-021-00193-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Accepted: 05/26/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Vasculitis damage index (VDI) is a validated damage index for systemic vasculitis, and as Behçet's disease is considered one of systemic vascular disease we aimed to study the relationship of the vasculitis damage index to clinical manifestations and comorbidity in patients with Behçet's disease (BD) to determine if VDI could be used to assess damage in patients with BD. METHODS A total of 109 patients with BD were recruited from the Rheumatology Department (outpatient and inpatient clinic), Cairo University Hospitals. All patients were subjected to full history taking, clinical examination, and routine laboratory investigations. Disease activity was assessed by the BD current activity form, and the VDI was calculated in all patients. The relationship of the VDI to the disease clinical manifestations was studied. Mann-Whitney and Kruskal Wallis tests were used to estimate differences in quantitative variables. Spearman correlation test was used to test for correlation between quantitative variables. RESULTS In the current study, the VDI ranged from 1 to 10, with a mean of 3.5 ± 1.8. It was significantly associated with total thrombosis (P = 0.022); total neurological manifestations (P = 0.000), especially stroke and cranial nerve affection; uveitis (P = 0.005); avascular necrosis (AVN) (P = 0.015); osteoporosis (P = 0.01); impaired vision (P < 0.0001); cataract (P < 0.0001); and diabetes (P = 0.012). Generally, immunosuppressive treatment was significantly associated with VDI (P = 0.039), especially cyclophosphamide (P < 0.0001), biological agent (P = 0.008), chlorambucil (P = 0.003), and anticoagulant (P = 0.02). VDI was also significantly correlated with age (P = 0.033), disease duration (P = 0.029), and duration of eye involvement (P = 0.003). CONCLUSION VDI is significantly associated with most disease parameters of BD, except for parameters such as mucocutaneous manifestations and uncomplicated venous thrombosis; however, further studies may be needed to establish BD-specific damage index.
Collapse
Affiliation(s)
- Fatema T Elgengehy
- Rheumatology and Rehabilitation Department, Cairo University, Cairo, Egypt.
| | - Sherif M Gamal
- Rheumatology and Rehabilitation Department, Cairo University, Cairo, Egypt
| | - Nesreen Sobhy
- Rheumatology and Rehabilitation Department, Cairo University, Cairo, Egypt
| | - Ibrahem Siam
- Internal Medicine Department, National Research Center, Cairo, Egypt
| | - Ahmed M Soliman
- Dermatology and venereology Department, National Research Center, Cairo, Egypt
| | - Ghada W Elhady
- Public Health Department, Cairo University, Cairo, Egypt
| | - Tamer A Gheita
- Rheumatology and Rehabilitation Department, Cairo University, Cairo, Egypt
| |
Collapse
|
4
|
Morshedy NA, Mohammed DF, Badr FM, Teama MAEM. The pattern of cardiovascular manifestations in Egyptian Behçet’s patients and its relation to disease activity. THE EGYPTIAN JOURNAL OF INTERNAL MEDICINE 2021. [DOI: 10.1186/s43162-021-00048-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
Behçet’s disease (BD) is also referred to as vascular BD when it frequently involves the heart and vessels. This study aimed to describe the cardiovascular manifestations in patients with BD and its correlation to disease activity. We conducted a cross-sectional study on 40 patients diagnosed with BD according to the International Criteria for Behçet’s Disease 2014. All the patients were subjected to detailed history taking, full clinical examination, lab investigations, resting electrocardiogram, trans-thoracic echocardiography, and carotid artery duplex for measuring intimal thickness, peripheral arterial and venous duplex, computed tomography pulmonary angiography, and full ophthalmological examination. Regarding the activity of the disease, it was assessed according to the score of Behçet’s Disease Current Activity Form (BDCAF).
Results
The most common cardiac manifestation was valvular lesion (67.5%) where the most frequently affected valve was the tricuspid valve (27.5%). Although 25% of patients had left ventricular diastolic dysfunction, only 5% had intracardiac masses. Approximately 52.5% of patients had vascular lesion (deep venous thrombosis 45%, arterial involvement 7.5% [as pulmonary artery thrombosis 5% and aneurysm 2.5%]). Increase in intima media thickness (IMT) was observed in 7.5% of patients, while 60% had abnormal lipid profiles. Hypercholesterolemia was the most common lipid abnormality (50%). BDCAF score range was 4–12, which was significantly correlated to multiple cardiovascular parameters as a mitral, tricuspid valve, and vascular venous involvement (p < 0.05), while not significantly correlated to lipid profile (p > 0.05).
Conclusion
Cardiovascular complications are frequent among patients with BD, even those who are asymptomatic; therefore, these complications must be screened for early detection and proper management.
Collapse
|
6
|
Alkazzaz AMH, Ebdan WR, Ghoben MK, Kareem ZT, Al-Harbi SJO. Behçet's disease in Iraq: new insights into the clinical and epidemiologic features in Middle-Euphrates region. Expert Rev Clin Immunol 2019; 16:109-112. [PMID: 31851853 DOI: 10.1080/1744666x.2019.1705786] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Objectives: Behçet's disease (BD) is a chronic multisystem disease that is classified as a vasculitis. Recent evidence shows that BD is an inflammatory disease at the crossroad between autoinflammatory and autoimmune syndromes. The objective of this study was to determine BD awareness in Iraq, assess the demographic variables, and observe the initial and major clinical manifestations.Methods: A cross-sectional study was conducted, including 105 patients, aged between 15 and 60 (mean 33.9) years, 57 males (54.3%) and 48 females (45.7%). All patients fulfilled the CIBD diagnostic criteria.Results: About 50% of patients were diagnosed by rheumatologists. Male to female ratio was 1.18:1, with evident female preponderance in patients diagnosed before 20 years old. The most frequent onset sign was oral aphthae. Ocular, genital, skin, neurologic and joint involvement followed in frequency.Conclusion: both doctors' and patients' awareness of BD is increased in Iraq. Early-onset BD tends to involve females more than males with a significant drop of male-to-female ratio as compared to previously reported in national and other Middle-Eastern studies. The clinical characteristics are comparable to those reported from other countries with higher neurologic involvement as compared to previous national reports.
Collapse
Affiliation(s)
| | - Wahab Razzak Ebdan
- Neurology unit, Internal medicine department, University of Babylon College of Medicine, Babylon, Iraq
| | - Mustafa Kareem Ghoben
- Neuroscience hospital, Iraqi Board for Medical Specializations, Baghdad, Iraq.,Rheumatology department, Marjan teaching hospital, Babylon, Iraq
| | | | | |
Collapse
|
8
|
Al Zahrani FM, Alsultan B, Alahmari H, Almannaa A, Asseri M, Alhayaza S, Aljaser F, Alamri A, Alasmari A, Somaily M, Alsabaani A. Behçet’s disease presentations and care outcomes in a tertiary hospital in south‐western Saudi Arabia. Int J Rheum Dis 2019; 22:1466-1473. [PMID: 31099192 DOI: 10.1111/1756-185x.13598] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2018] [Revised: 02/11/2019] [Accepted: 03/21/2019] [Indexed: 12/25/2022]
Affiliation(s)
| | | | - Hana Alahmari
- Internal Medicine Department, College of Medicine King Khalid University Abha Saudi Arabia
| | - Ali Almannaa
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Malak Asseri
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Shahad Alhayaza
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Fatimah Aljaser
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Alwaleed Alamri
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Ali Alasmari
- College of Medicine King Khalid University Abha Saudi Arabia
| | - Mansour Somaily
- Internal Medicine Department, College of Medicine King Khalid University Abha Saudi Arabia
| | - Abdullah Alsabaani
- Community Medicine Department, College of Medicine King Khalid University Abha Saudi Arabia
| |
Collapse
|